Penile Prosthesis in Patients With Erectile Dysfunction
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: inflatable penile prosthesis (IPP).
- Who it may be relevant to
- Registry conditions: Erectile Dysfunction. Basic parameters: 18 years — 80 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Assessment of Safety and Efficacy of Inflatable Penile Prothesis in Patients With Erectile Dysfunction
Overview
Erectile dysfunction (ED) is defined as the persistent inability to attain and or maintain an erection sufficient to permit satisfactory sexual performance
Detailed description
In the literature, well- designed studies evaluating safety and efficacy of inflatable penile prosthesis (IPP) is lacking. So, this series aimed at investigating this prospectively.
Interventions
- Device inflatable penile prosthesis (IPP)
inflatable penile prosthesis (IPP)
Primary outcome measures
- Number of patients with improved erectile dysfunction [Time frame: 3 years]
Eligibility criteria
Inclusion criteria
- Patients complaining of ED with contraindication or failure of medical treatment
Exclusion criteria
- Patients lacking manual dexterity or mental abilities necessary to operate the pump
- General contraindications as uncorrectable bleeding tendency
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Tanta university - faculty of medicine — Cairo
Identifiers
NCT: NCT03466619 · Khaled Hafez